Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Novello

Showing results (1-10 of 404) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors As Adjuvant Therapy in Completely Resected Non-Small-Cell Lung CancerSilvia Novello
Lung Cancer Management|January 16, 2019
Interview: developing therapies for lung cancerSilvia Novello
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2010
Strategies for prolonged therapy in patients with advanced non-small-cell lung cancerPanos Fidias, Silvia Novello
Therapeutic Advances in Medical Oncology|August 10, 2018
Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapyTiziana Vavalà, Silvia Novello
Journal of Thoracic Disease|June 29, 2018
Immunotherapy & thoracic cancersAntonio Rossi, Silvia Novello
Lung Cancer (Amsterdam, Netherlands)|November 13, 2003
Adjuvant chemotherapy after complete resection for early stage NSCLCGiorgio Scagliotti, Silvia Novello
Translational Lung Cancer Research|January 25, 2021
Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?Francesco Passiglia, Silvia Novello
Translational Lung Cancer Research|December 21, 2019
Expanding anaplastic lymphoma kinase therapeutic indication to early stage non-small cell lung cancerFabrizio Tabbò, Silvia Novello
Annals of Translational Medicine|February 12, 2019
Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle?Francesco Passiglia, Silvia Novello
Eclinicalmedicine|February 23, 2023
Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?Francesco Passiglia, Silvia Novello
Pageof 41

Showing results (1-10 of 404) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors As Adjuvant Therapy in Completely Resected Non-Small-Cell Lung CancerSilvia Novello
Lung Cancer Management|January 16, 2019
Interview: developing therapies for lung cancerSilvia Novello
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2010
Strategies for prolonged therapy in patients with advanced non-small-cell lung cancerPanos Fidias, Silvia Novello
Therapeutic Advances in Medical Oncology|August 10, 2018
Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapyTiziana Vavalà, Silvia Novello
Journal of Thoracic Disease|June 29, 2018
Immunotherapy & thoracic cancersAntonio Rossi, Silvia Novello
Lung Cancer (Amsterdam, Netherlands)|November 13, 2003
Adjuvant chemotherapy after complete resection for early stage NSCLCGiorgio Scagliotti, Silvia Novello
Translational Lung Cancer Research|January 25, 2021
Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?Francesco Passiglia, Silvia Novello
Translational Lung Cancer Research|December 21, 2019
Expanding anaplastic lymphoma kinase therapeutic indication to early stage non-small cell lung cancerFabrizio Tabbò, Silvia Novello
Annals of Translational Medicine|February 12, 2019
Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle?Francesco Passiglia, Silvia Novello
Eclinicalmedicine|February 23, 2023
Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?Francesco Passiglia, Silvia Novello
Pageof 41